Abstract
This article discusses current recommendations for lung cancer screening, as well as some of the similarities and differences between the clinical practice guidelines of the European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), and National Comprehensive Cancer Network (NCCN) for treatment of lung cancer. This article also compares these guidelines for early-stage and locally advanced non—small cell lung cancer (NSCLC), demonstrating that despite their similarities, there are often subtle differences in their recommendations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.